Video & Transcript : 'opioid prevention' :
Page 29 of 500
KY
Kentucky 2026 Regular Session
Senate Standing Committee on Health Service (3-11-26)
Transcript Highlights:
- Funding will come from the opioid settlement money, which was placed in the opioid abatement trust fund
- placed opioid settlement money which was placed in<00:20:18.080><c> the</c><00:20:18.240><c> opioid<
- </c> funding Senate Bill 77 from the opioid funding Senate Bill 77 from the opioid trust<00:20:59.280
- ><c> trust</c><00:21:59.200><c> fund</c> that leaves the opioid trust fund that leaves the opioid trust
- </c> Part of the intent of the opioid Part of the intent of the opioid abatement<00:48:52.079><c> fund
Summary:
The committee first reviewed preferred administrative regulations and, hearing no concerns, considered them reviewed. It then took up House Bill 388, described as a Casper cleanup bill. The sponsor said it would exempt charitable health care providers from e-prescribing requirements, allow Casper data sharing with certain federal entities, update references to hydrocodone’s schedule status, clean up drafting errors, and clarify practitioner registration with Casper. The bill passed 9-0 and was then approved for consent.
Next, House Bill 134 was presented as a follow-up to a prior study on shortages of sexual assault nurse examiners and SANE-ready hospitals. The sponsor and a representative from the Kentucky Association of Sexual Assault Programs said the bill would create a statewide SANE coordinator. The committee adopted a substitute, then passed the bill unanimously and sent it to consent. Senate Bill 147 was then heard as an administrative update to vital records, modernizing certified-copy requests, adjusting fees, and requiring the Cabinet for Health and Family Services to send the annual death report to the State Board of Elections by July 1 each year. It passed unanimously and was also moved to consent.
House Bill 280, a Kentucky Board of Nursing cleanup bill, would let the board investigate out-of-state nurses applying for Kentucky licenses, clarify licensing language, and update school rescue medication provisions, including inhalers, nebulizers, glucagon, Solu-Cortef, and nasal epinephrine. A committee substitute narrowed the bill to glucagon updates, and one senator asked whether the bill also covered child care centers; the sponsor said it addressed school medications only but was open to further discussion. The bill passed 10-0 and was reported favorably.
Finally, Senate Bill 77 drew extended testimony. The sponsor and supporters argued that ibogaine research and treatment could help address addiction, PTSD, and depression, citing studies, personal recovery stories, and a proposed public-private partnership funded through opioid settlement money. The committee substitute removed the bill’s appropriation request and emergency clause, and members asked questions about whether PTSD is an addiction, whether smoking was included, whether the bill was authorizing research rather than funding, and how the treatment works. The sponsor said the substitute was only creating a structure for research, not appropriating money, and supporters described ibogaine as a one-time, medically supervised treatment. The transcript cuts off before a final vote on Senate Bill 77 is shown.
MA
Massachusetts 2025-2026 Regular Session
Joint Committee on Mental Health, Substance Use and Recovery Jun 21st, 2026 at 01:00 pm
Joint Committee on Mental Health, Substance Use and Recovery
Transcript Highlights:
- I think education and prevention is such a big part of that.
- I think it's critical education prevention is such a big part of that.
- They want overdose prevention offered in school settings.
- to treatment, and we are also teaching them about overdose prevention.
- It will help prevent years of misdiagnosis, emotional pain, and costly interventions.
Summary:
The Joint Committee on Mental Health, Substance Use and Recovery opened its first public hearing of the 2025–26 session with remarks from the Senate and House chairs outlining the committee’s priorities. They noted recent work on addiction and recovery legislation, the ongoing youth behavioral health crisis, and that members might need to leave periodically for floor votes. The chairs explained hearing procedures, including three-minute testimony limits, written testimony deadlines, and reporting deadlines for Senate and House bills. The hearing then focused on several bills related to youth mental health, overdose prevention, and psychedelic treatment research.
A major portion of the hearing centered on bills to improve youth crisis response and overdose prevention. Testimony strongly supported bills to print the 988 Suicide and Crisis Lifeline on student ID cards, with speakers from mental health organizations, crisis centers, and individuals sharing personal stories of depression, suicide attempts, and the importance of making 988 as familiar as 911. Another set of bills would require schools to stock naloxone and provide overdose prevention education. Physicians, harm reduction advocates, students, and grieving family members testified that school-based Narcan access and education could save lives, reduce stigma, and help students recognize overdoses and understand Good Samaritan protections. Senator O’Connor and Tamika Perry also testified for a bill to strengthen substance use prevention education and reduce overdose abandonment, emphasizing the need to teach students about overdose risks and the legal protections for calling 911.
The committee also heard testimony on a bill to authorize a pilot program for psychedelic treatment in licensed facilities. Senator Friedman and several medical and behavioral health professionals argued the proposal was a narrow, research-based approach distinct from the broader ballot question rejected in 2024. They said the bill would allow only a small number of supervised clinics to use psychedelics for conditions such as depression, PTSD, anxiety, and substance use disorders, with data reporting and Department of Public Health oversight. Supporters described it as a cautious way to study promising treatments while avoiding unsupervised or commercialized use.
Finally, the committee heard support for a bill to create a special commission and five-year strategic plan for children’s behavioral health services, with testimony that the current system is fragmented, difficult for families to navigate, and strained by workforce and funding challenges. No votes or final actions were taken during the hearing; the committee primarily received testimony and questions on the bills.
WA
Washington 2025-2026 Regular Session
House Consumer Protection & Business Jan 30th, 2026
Transcript Highlights:
- Did you say it was an opioid or did you say that it was an alkaloid?
- So it is an opioid, but they're also alkaloids. Does that make sense? Madam Chair. Madam Chair.
- So, I mean, the opioid framework is good, especially as it comes, as it equates to 7-OH.
- solidarity with my fellow prevention leaders and with the youth across Washington.
- As youth, we are asking you to act now because prevention matters.
Summary:
The Consumer Protection and Business Committee held a public hearing on House Bill 2291, the Kratom Consumer Protection Act, and then moved into executive session on several bills. Staff explained that HB 2291 would license kratom retailers and processors, set age 21 purchase limits, require labeling, child-resistant packaging, independent testing, an LCB-approved product directory, and an 11% excise tax, while banning certain synthetic or adulterated kratom products and restricting online/mail sales and public consumption. The prime sponsor said the bill was intended to regulate natural kratom while banning the synthetic or chemically altered forms, and several witnesses supported stronger youth protections and product standards. Others opposed the bill’s licensing fee, statewide preemption of local bans, or the regulatory approach, while some testified that natural kratom helps with pain or recovery. The hearing on HB 2291 was then closed without action.
In executive session, the committee took action on multiple bills. HB 2439, dealing with cigarette, vapor product, and tobacco product policy, was amended and reported out with a do pass recommendation; the adopted amendments limited Consumer Protection Act enforcement to the Attorney General, adjusted coupon language, and restored state preemption over local retail regulation. HB 1078 on pet insurance, HB 1701 on shared liquor-license premises, HB 2207 on bonded beer warehousing, and HB 2501 on real estate oil-tank disclosure were all reported out with do pass recommendations, with HB 1701’s substitute removing a Public Records Act exemption and HB 2207’s substitute aligning beer warehousing more closely with spirits warehouse rules. HB 2361, which raises the maximum small loan amount, was amended to make inflation adjustments biennial and to change publication requirements, then passed out of committee.
The committee also approved HB 1932, which would authorize cannabis consumption events in regulated environments. The substitute bill would create a cannabis consumption event organizer license, allow limited adult-use events subject to local approval, and establish permit and budtender training requirements; members discussed the bill as a way to provide lawful consumption spaces while others objected to expanding cannabis access. In the final votes, HB 2439 passed 12-3, HB 1078 passed unanimously, HB 1701 passed 14-1, HB 2207 passed 14-1, HB 2501 passed unanimously, HB 2361 passed 13-2, and HB 1932 passed 11-4, all with do pass recommendations.
CO
Colorado 2026 Regular Session
Colorado Senate 2026 Legislative Day 094 Apr 18th, 2026
Colorado Senate Floor Meeting
Transcript Highlights:
- </c> to opioid pain medications. to opioid pain medications.
- </c> properties that opioids have. properties that opioids have.
- Nonopioids and opioids should opioids.
- </c> opioid option. opioid option. >> Senator<01:00:11.280><c> Amab.
- To opioid addiction.
NH
New Hampshire 2025 Regular Session
House Finance Division III (02/27/2025)
Transcript Highlights:
- </c> time so there is a suicide prevention time so there is a suicide prevention Council<01:00:10.760
- There's a prevention unit that oversees their prevention contract.
- There's a prevention unit that oversees their prevention contract.
- ...the Prevention Services 3380.
- Page 56 is overdose prevention.
Summary:
The House Finance Committee’s Division 3 held a public work session on the Behavioral Health budget on February 27, 2025. The chair opened by explaining the schedule, materials, and deadlines for the budget process, and noted there would be no motions or votes in the division that day. Division of Behavioral Health Director Ktia Fox and DHHS CFO Nathan White then walked the committee through the division’s mission, structure, and budget materials, describing the division’s four bureaus: Mental Health Services, Children’s Behavioral Health, Drug and Alcohol Services, and Homeless Services, along with the policy unit. They emphasized the division’s role in oversight, technical assistance, quality assurance, contracting, and the continuum of care from prevention and early intervention through crisis and residential services.
Much of the discussion focused on major programs and funding lines, including the 988 Lifeline contract with Headrest, a technical assistance contract with UNH, Medicaid pass-through payments to New Hampshire Hospital and Glencliff, crisis response services, cold-weather homeless responses, housing supports, and the children’s system of care. Members asked about the UNH contract, the 988 program, crisis stabilization centers, and the peer certification program; Fox explained that the peer certification is a training-and-credentialing pathway for people with lived experience to enter community-based behavioral health work, not a volunteer program. The committee also discussed the “Choose Love” program, which Fox said was created after the Sandy Hook tragedy to build resilience and strength-based emotional regulation in schools and communities.
On the children’s side, Fox described the system of care account as the place where many contracted services are budgeted, including community mental health centers, care management entities, rapid response services, and residential programs. Members asked about temporary staffing, and Fox said roughly $500,000 in temporary staff costs shown in the current year would not be spent next year because the money came from a nonlapsing appropriation in HB 1573 for oversight of children’s residential services. She also said provider rate increases were a prioritized need but were not funded in the governor’s current budget, and that the Children’s Behavioral Health Resource Center was not funded, resulting in about a $1 million reduction. The session ended while the division was still moving through the children’s behavioral health slides, including questions about the Fast Forward high-fidelity wraparound program and medication management.
CA
California 2025-2026 Regular Session
Assembly Budget Subcommittee No. 1 on Health Mar 17th, 2025
Transcript Highlights:
- Hospital visits, as hospital outpatient upticks, as opposed to preventative care.
- And really recover and have access to more prevention and more upstream efforts to really prevent hospitalization
- , prevent institutionalization.
- I can cover the opioid settlement fund. Yes.
- It's a reevaluation of opioid settlement funds and...
Summary:
The committee heard a budget oversight hearing on the Department of Health Care Services, focusing first on the overall Medi-Cal budget and a March General Fund loan to cover a current-year shortfall. DHCS said the 2025-26 budget proposal totals $193.4 billion, with Medi-Cal projected at $188.1 billion total funds and $42.1 billion General Fund, driven by higher enrollment, pharmacy costs, managed care growth, and costs tied to eligibility expansions and the COVID-era redetermination unwinding. The department said the $3.44 billion loan was needed to manage cash flow and ensure timely payments to providers and plans, while the LAO noted Medi-Cal’s cash-basis budgeting creates volatility and that more detailed estimates would come with the May Revision. Members discussed federal Medicaid threats, the need for transparency on cost drivers, and the impact of pharmacy spending, long-term care, and immigration-related coverage expansions.
The second major topic was family health programs, including California Children’s Services, the continuous coverage unwinding, and opioid settlement fund spending. DHCS described CCS funding methodology changes, ongoing county stakeholder work, and a delayed rollout of CCS monitoring and oversight until July 1, 2025, while county representatives and advocates argued the program is underfunded and asked for more technical assistance and a delay in implementation. On the unwinding, the department explained that federal redetermination flexibilities helped maintain coverage after the pandemic, but the Governor’s budget proposes ending them at the end of June 2025; advocates urged making the flexibilities permanent to avoid coverage losses. For opioid settlement funds, DHCS and Finance said the budget increases funding for naloxone distribution while reducing other harm-reduction spending based on updated settlement revenues, prompting criticism from members and public commenters who argued the change would weaken effective harm-reduction programs.
The hearing also included an update on Proposition 35 implementation. DHCS said the voter-approved measure continuously appropriates MCO tax revenues beginning in 2025, with up to $4.6 billion annually available for specified Medi-Cal and provider investments in 2025 and 2026, but implementation depends on consultation with the required stakeholder advisory committee. The department and LAO noted uncertainty about future federal rules affecting the MCO tax after 2026. Public testimony largely supported maintaining Medi-Cal expansions, protecting immigrant coverage, preserving harm-reduction funding, and increasing support for community health workers, pediatric dental care, and CCS county administration. No votes were taken during the portion of the hearing provided.
MN
Minnesota 2025-2026 Regular Session
Committee on Health and Human Services - Part 2 - 03/24/26
Health and Human Services
Transcript Highlights:
- While I am trained in the treatment of opioid use disorder, current limitations prevent me from utilizing
- </c> opioid use disorder or OUD. opioid use disorder or OUD.
- </c> am trained in the treatment of opioid am trained in the treatment of opioid use<00:04:01.680><c>
- </c><01:21:56.400><c> prevention</c> responsive and prevented prevention responsive and prevented prevention
- </c> to prevent improper waste handling. to prevent improper waste handling.
Committee:
Senate Health and Human Services
TX
Transcript Highlights:
- Kratom has a substantial benefit, particularly in the opioid space.
- When people are addicted to opioids, you'll...
- Some of these are opioid systems, but most of them are not.
- I will just reemphasize that Kratom is not an opioid.
- To assess it as an opioid use disorder.
Bills:
SB31 , SB33 , SB510 , SB871 , SB1868 , SB2024 , SB2166 , SB2309 , SB2880 , SJR27 , SJR39 , SJR40 , SB 31 , SB 33
Committee:
Senate State Affairs
Keywords:
SB 31, Life of the Mother Act, Texas abortion law, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, spontaneous abortion, miscarriage, unborn child, abortion exception, abortion ban, physician liability, health care liability claim, aiding and abetting, Texas Medical Board, State Bar of Texas, continuing medical education
FL
Florida 2025 Regular Session
January 15, 2025 - 01:00 PM
Transcript Highlights:
- We've continued to aggressively battle the opioid epidemic with comprehensive prevention, treatment,
- prevention space.
- prevention space.
- They asked how much of the budget is going toward preventive care, early diagnosis, and prevention, starting
- They asked how much of the budget goes toward preventive care, prevention for early diagnosis, and preventive
Summary:
The Health Care Budget Subcommittee met to organize the new term, take roll, and hear introductory presentations from the six agencies under its jurisdiction: the Agency for Health Care Administration, Agency for Persons with Disabilities, Department of Children and Families, Department of Elder Affairs, Department of Health, and Department of Veterans’ Affairs. The chair outlined the committee process, including assigning members to review agencies and make budget recommendations. Each agency head gave a high-level overview of their budget, staffing, major programs, and priorities, with recurring themes including Medicaid, long-term care, disability services, child welfare, mental health, aging services, public health, and veterans’ health care.
Several agency leaders highlighted recent initiatives and funding priorities. AHCA emphasized Medicaid managed care, provider regulation, Hope Florida, hospital-at-home, and cancer-related efforts; APD discussed iBudget services, Hope Florida, a managed-care pilot, online applications, and forensic care costs; DCF focused on child protection, foster care, adult protective services, food/cash/medical assistance, mental health, and opioid treatment; Elder Affairs highlighted Alzheimer’s services, community-based senior care, guardianship, ombudsman services, and disaster outreach; DOH covered cancer innovation, maternal telehealth, cybersecurity, HIV/hepatitis/syphilis screening, and school nursing; and Veterans Affairs described benefits and health care access for veterans, long-term care, and federal reimbursement. Several speakers also raised concerns about rising costs, provider rates, disaster response, and access to services.
The committee heard two public comments from disability advocates about Medicaid redeterminations affecting iBudget waiver recipients and provider payment delays. In response, AHCA and APD said they were coordinating on data sharing, early outreach, escalation processes, and efforts to reduce disenrollments and make recertification smoother. Members then asked questions about provider rates, opioid settlement spending, managed care quality measures, pediatric rare disease grants, group home transparency, senior outreach, ABA services moving into managed care, annual Medicaid recertification, veterans’ service utilization, waiting lists for elder services, and prevention spending. No formal votes were taken during the meeting.
NH
New Hampshire 2026 Regular Session
House Criminal Justice and Public Safety (04/08/2026)
Criminal Justice and Public Safety
Transcript Highlights:
- </c> pharmacologically like opioids. pharmacologically like opioids.
- </c> >> Someone who's already taking an opioid >> Someone who's already taking an opioid
- </c> opioids, you should not take this? opioids, you should not take this?
- </c> >> an opioid. >> an opioid.
- Well, opioid.
Committee:
House Criminal Justice and Public Safety
MN
Transcript Highlights:
- Section 5 adds preventing and detecting theft.
- They've stepped forward with research, including testimonies in bold. ideas on how to prevent further
- Kalik Rogers' comments regarding the bill. the opioid issue.
- The opioid epidemic has been affecting our country for three decades, and it's an issue that is impacting
- That's something that, you know, We can address the opioid epidemic in many ways, and we have for three
Bills:
HF1306
Committee:
House Education Policy
MS
Transcript Highlights:
- overdoses and opioid-related deaths.
- 30 days on that opioid.
- overdoses and opioid-related deaths.
- 30 days on that opioid.
- opioids opioids with<00:04:52.639><c> cost</c><00:04:53.520><c> and</c><00:04:53.840><c> insurance</
Committee:
Joint Medicaid
AL
Alabama 2025 Regular Session
Alabama Joint Legislative Budget Hearings (PM) Feb 6th, 2025
Transcript Highlights:
- Is there a law preventing us from doing that? We'd have to dig in a little bit.
- definitive answers about what the local opioid... ...answers about what the local opioid money is going
- We didn't fully fund it out of the opioid dollars, did we? We did not.
- Next, opioid funding, Mr... Budgeting, uh, next, so opioid funding. Mr.
- Almost all of it is going into treatment and prevention care.
US
US Federal 2025-2026 Regular Session
US House Floor Proceedings (Wednesday, June 11, 2025)
US Federal House Floor Meeting
Transcript Highlights:
- The president's budget also calls for reducing opioid overdose prevention and surveillance by $29 million
- The president's budget also calls for reducing opioid overdose prevention and surveillance by $29 million
- The president's budget also calls for reducing opioid overdose prevention and surveillance by $29 million
- The president's budget also calls for reducing opioid overdose prevention and surveillance by $29 million
- So, this is an assault on every effort for prevention and treatment of opioid disorders, whether it's
CA
California 2025-2026 Regular Session
Assembly Budget Subcommittee No. 1 on Health Mar 17th, 2025
Transcript Highlights:
- Continuous coverage unwinding or the overdose prevention and harm reduction initiatives.
- prevent hospitalization.
- Yes, so the state has received over $300 million in opioid settlement funds.
- It is unconscionable that the state of California has rules in place that prevent this.
- Of course, we need more definition on that, the opioid settlement, and harm reduction.
CO
Colorado 2026 Regular Session
Colorado Senate 2026 Legislative Day 097 Apr 21st, 2026
Colorado Senate Floor Meeting
Transcript Highlights:
- </c> non-opioid pain management drugs. non-opioid pain management drugs.
- </c> that are not opioids. that are not opioids.
- I think we have to keep in mind where we still are. 35 of 100 prescriptions written are opioid class
- And this is a case where we're obviously addressing the opioid crisis at the same time.
- </c><00:43:12.600><c> fiscal</c> facing a largely preventable fiscal facing a largely preventable fiscal
AZ
Arizona 2026 Regular Session
02/19/2026 - House Health & Human Services
House Health & Human Services Committee of Reference
Transcript Highlights:
- prescription drugs than those applied to opioid or narcotic drugs.
- non-opioid therapies are not available?
- So I want to clarify first that neither Access nor the health plans ever substitute an opioid for a non-opioid
- get access to a non-opioid medication.
- pain reliever without trying a non-opioid first.
Summary:
The Special Committee on Health and Human Services heard a series of continuation and board-reform bills, beginning with core review measures to continue the Arizona Department of Economic Security, the State Board of Nursing, the Board of Occupational Therapy Examiners, the Regulatory Board of Physician Assistants, and the State Board of Pharmacy. HB 2728, HB 2729, HB 2730, HB 2731 as amended, and HB 2732 all received due-pass recommendations, with the physician assistant board bill amended to extend the board for four years rather than two. The committee then moved to reform bills affecting the nursing board and pharmacy board, as well as a reconsidered health plan drug-coverage bill.
HB 2408, which would change nursing board complaint procedures, prioritize certain allegations, allow limited expungement of disciplinary records, and adjust evidentiary and liability standards, drew extensive testimony. Nursing board leadership opposed the bill, arguing it would weaken patient safety, raise the burden of proof, and erase useful disciplinary history, while supporters said it would improve fairness, reduce backlog, and give nurses a second chance for non-patient-safety-related issues. After debate, the committee adopted an amendment and advanced the bill on a 7-4-1 vote. HB 2434, updating the controlled substances prescription monitoring program and related reporting and confidentiality rules, and HB 2733, changing pharmacy continuing education timing, delivery rules, and ownership-transition procedures, both passed unanimously after amendments.
The committee also reconsidered HB 2725, which would limit access contractors’ use of therapeutic substitution and utilization controls for certain non-opioid drugs. Access and health plan representatives warned the bill was too broad and could significantly increase costs by affecting many drug classes, while the sponsor said the amendment was intended to address those concerns and preserve the policy goal. After the amendment was adopted, the bill failed on a 6-? vote and did not receive a due-pass recommendation. The chair then announced the committee was done hearing House bills and adjourned, with Senate bills expected in a later meeting.
TX
Transcript Highlights:
- preventative care.
- Opioid antagonists reverse or reduce the effects of an opioid overdose.
- By illicit fentanyl, which is a synthetic opioid.
- State and federal money has been invested in battling opioid overdoses, and the use of opioid antagonists
- Opioid antagonist program.
Bills:
HB46 , HB35 , HB4490 , HB4454 , HB2188 , HB3078 , HB4743 , HB2556 , HB46 , HB5342 , HB4783 , HB3785 , HB5278 , HB1639 , HB2581 , HB4224 , HB4070 , HB4099 , HB4882 , HB3794
Committee:
House Public Health
Keywords:
local government spending cap, expenditure limit, political subdivision, property tax, ad valorem tax, budget cap, taxpayer protection, spending restraint, inflation adjustment, population growth, voter approval, supermajority vote, county budget, municipal budget, school district finance, junior college district, hospital district, special district, attorney general enforcement, local fiscal limits
NM
New Mexico 2025 Regular Session
IC - Legislative Health and Human Services Nov 5th, 2025
Legislative Health & Human Services Committee
Transcript Highlights:
- When considering youth opioid-related deaths, youth deaths have increased exponentially.
- Individuals who use meth are less likely to die, overdose, or continue to use opioids.
- It's preventing it from happening. Okay. Thank you, Madam Chair.
- So also, on the number of opioid-related deaths for ages 12 to 17, this is 280 percent.
- You know, these drugs are expensive, but if we prevent.
MO
Transcript Highlights:
- The other question is, would you consider that an opioid, the 7-OH—an opioid?
- Partial mu-opioid agonists.
- It's not just a mu-opioid receptor agonist. It actually blocks several types of opioid receptors.
- It blocks the kappa opioid receptor. It blocks the delta opioid receptor.
- And besides opioid addiction, 23% were using the substance to help abstain from opioid use.
Committee:
House Emerging Issues